🚚 Free UK delivery on orders over £100

CJC-1295 No DAC + Ipamorelin Blend

£38.99

Fixed 10mg research blend containing CJC-1295 without DAC 5mg and Ipamorelin 5mg. For laboratory, analytical and scientific research only. Not for human or veterinary use.

Buy More, Save More Bulk discounts applied automatically
SKU: ZP-CJCIPA-10MG Categories: , Brand:
Verify COA / Third-Party Test Result

Each CJC-1295 No DAC + Ipamorelin Blend batch is supported by an independent third-party analytical report. Testing includes HPLC purity analysis and mass spectrometry identity confirmation.

  • Batch referenceZC0018
  • HPLC purity99.11%
  • Testing laboratoryFreedom Diagnostics Testing

Use the batch number printed on the product label to confirm the report that corresponds to your supplied batch.

Description

For Research Use Only. This product is supplied exclusively for laboratory research and is not intended for human or veterinary use.

CJC-1295 without DAC and Ipamorelin Research Blend

This fixed 10mg lyophilised blend contains 5mg CJC-1295 without DAC and 5mg Ipamorelin. The components act through different receptor systems within growth-hormone-axis research.

CJC-1295 without DAC is a GHRH-receptor agonist analogue. Ipamorelin is a growth-hormone secretagogue receptor/ghrelin-receptor agonist. A fixed blend does not prove synergy or permit independent adjustment of the two components.

Technical Specifications

CJC-1295 without DAC5mg
Ipamorelin5mg
Total content10mg
Mass ratio1:1
Research receptorsGHRH receptor and GHSR/ghrelin receptor
PurityCurrent batch records above 99% by third-party HPLC testing
Physical formCombined lyophilised research material
Intended useLaboratory research and analytical use only

Independent Batch Testing

The current blend batch is independently analysed and records an HPLC purity result above 99%. Use the batch number on the label to view the matching report in the Batch Verification and COA Centre.

Blend Research Context

Research has used GHRH-receptor agonists and ghrelin-receptor agonists to examine complementary signalling inputs to pituitary growth-hormone release. The two components remain pharmacologically distinct.

The individual product pages provide the corrected molecular identity and evidence limitations. Researchers needing separate controls or variable ratios should use individual vials.

Storage and Handling

Keep unopened lyophilised material at approximately -20°C for long-term storage or 2-8°C for short-term laboratory storage. Protect from light, moisture and repeated temperature changes.

CJC-1295 and Ipamorelin Blend FAQs

What is in the blend?

It contains 5mg CJC-1295 without DAC and 5mg Ipamorelin.

Does this contain the DAC modification?

No. The CJC component is the without-DAC analogue.

Do both compounds target the same receptor?

No. They act through GHRH-receptor and ghrelin-receptor pathways respectively.

Can the ratio be adjusted?

No. The blend has a fixed 1:1 mass ratio.

How is the batch verified?

The current blend batch is independently HPLC tested above 99% and linked to an online report.

Is it intended for human use?

No. It is supplied only for controlled laboratory research.

Research Resources

For research use only. Not for human or veterinary use.

Read our research guide comparing CJC-1295 with DAC and without DAC.

Additional information

Weight0.05 g
Brand

ZENTRA

Reviews

There are no reviews yet.

Rate this product

Your email address will not be published. Required fields are marked *

Product ratings are available to verified customers after purchase.

ZENTRA